Ian has over 30 years of healthcare & pharmaceutical industry experience. Prior to Juno Pharmaceuticals Corp., Ian worked for Arrow Pharmaceuticals, where he primarily served as the CEO of Cobalt Pharmaceuticals from 2000 – 2010. At Cobalt, Ian was responsible for over $300 million in annual sales and he was also instrumental in the development of Arrow’s other international business units. The Arrow Group was sold to Watson Pharmaceuticals (now Teva) in June 2009 for over $2.4 billion USD.

Prior to his work at Arrow, Ian worked for Par Pharmaceuticals (US) in the Office of the President, Genpharm Canada as Executive Vice President, and Amerpharm/Merck KGaA as a Senior Executive.